People channel feed – Endpoints News

People channel feed

Lifetime pharma ban? ‘Pharma Bro’ returns with ‘software’ company for drug discovery

3 years ago

'Go quickly': Amgen R&D vet Dirk Nagorsen jumps to a startup with big plans for TCRs

3 years ago

Astellas gathers scattered cell and gene therapy, BD units in new $70M South San Francisco hub

3 years ago

Biden to tap Harvard surgeon, clinical trials expert as NCI director

3 years ago

X4 slashes pipeline, lays off staff just three weeks after netting a $55M PIPE

3 years ago

John McHutchison throws in the towel on HBV drug, triggering layoffs as Assembly shifts to next-gen approaches

3 years ago

After 14 years as Roche’s CEO, Severin Schwan is passing the baton

3 years ago

San Francisco cell therapy player lays off 94 staffers as it awaits data on lead candidate

3 years ago

As the pandemic high wanes, Inovio chops headcount again while chasing Covid win

3 years ago

Shortly after selling Sierra to GSK, Stephen Dilly heads to enzyme engineer Codexis as new CEO

3 years ago

Cancer Moonshot moves forward with new 'Cancer Cabinet' and goals to reduce cancer

3 years ago

Pharma hiring continues to grow in the US and talent competition remains tight — report

3 years ago

Reeling from PhII flop, CytomX lays off 40% as execs go back to drawing board, seek new deals

3 years ago

After architecting Agios’ oncology exit and R&D pivot, Jackie Fouse hands keys to former Alexion exec

3 years ago

Novo Nordisk workers in Korea protest after breakdown in salary and perks negotiations — report

3 years ago

Adverum lays off 38% of staff as it enters new trial for ocular gene therapy after last year's safety woes

3 years ago

Pulmonologist and frequent NBC guest in consideration for senior role at FDA — report

3 years ago

Catalent’s new CEO takes the reins as the drug manufacturer adjusts its operational structure

3 years ago

Bill Haney's latest startup scores deal from Sanofi, its newest Big Pharma partner, with $54M upfront

3 years ago

'We strongly dissent': Women biotech execs pen letter to colleagues and politicians in Roe v. Wade aftermath

3 years ago

Teva chief raids Vertex for his new global head of research and development

3 years ago

Another biotech grabs the axe, chopping R&D in a major reorganization as drug sales disappoint

3 years ago

Scoop: A small gene therapy biotech, flush with ex-Sarepta and bluebird leaders, guts CMC

3 years ago

Little biotech makes deep cuts as it struggles to get narcolepsy drug approved amid months of regulatory limbo

3 years ago

First page Previous page 40 41 424344 45 46 Next page Last page